Which has grown faster, ADMA or SUPN?

Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus SUPN at 7.78%.

Is ADMA or SUPN more profitable?

ADMA runs the higher net margin — ADMA at 32.98% versus SUPN at -13.23%.

How have ADMA and SUPN total returns compared?

Over the past 10 years, ADMA delivered 3.85% and SUPN delivered 5.87% annualized total return. Past performance doesn't predict future results.

ADMA Biologics, Inc. (ADMA) vs Supernus Pharmaceuticals, Inc. (SUPN)

A side-by-side comparison of ADMA Biologics, Inc. and Supernus Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADMA

ADMA Biologics, Inc.

$2.36B

$10.18HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SUPN

Supernus Pharmaceuticals, Inc.

$2.49B

$42.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ADMA vs SUPN

growth of $100 · dividends reinvested · last 10y

ADMA +50.9% (+4.2%/yr)SUPN +79.4% (+6.0%/yr)SUPN compounded faster over this window

ADMA SUPN

ADMA vs SUPN: by the numbers

•SUPN is the larger company ($2.49B vs $2.36B market cap).
•ADMA is profitable (32.98% net margin) while SUPN runs a net loss (-13.23%).
•ADMA grew revenue faster over the past five years (54.55% vs 7.78% CAGR).

Metrics side by side

Valuation

Metric	ADMA	SUPN
P/E ratio	14.54	N/A
Forward P/E	12.78	16.70
P/S ratio	4.61	2.99
P/B ratio	5.78	2.41
EV / EBITDA	10.74	N/A
FCF yield	4.94%	0.76%

Profitability

Metric	ADMA	SUPN
Gross margin	64.71%	88.07%
Operating margin	42.26%	-5.13%
Net margin	32.98%	-13.23%
ROE	41.39%	-10.66%
ROIC	27.60%	-10.24%

Growth (annualized)

Metric	ADMA	SUPN
Revenue CAGR (5Y)	54.55%	7.78%
FCF CAGR (5Y)	N/A	-30.77%
Total return CAGR (5Y)	54.74%	9.85%

Frequently asked

Which has grown faster, ADMA or SUPN?: Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus SUPN at 7.78%.
Is ADMA or SUPN more profitable?: ADMA runs the higher net margin — ADMA at 32.98% versus SUPN at -13.23%.
How have ADMA and SUPN total returns compared?: Over the past 10 years, ADMA delivered 3.85% and SUPN delivered 5.87% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADMA analysis Full SUPN analysis Interactive comparison tool

Dig into the metrics

ADMA Biologics P/E ratio ADMA Biologics ROE Supernus Pharmaceuticals ROE ADMA Biologics operating margin Supernus Pharmaceuticals operating margin ADMA Biologics revenue growth Supernus Pharmaceuticals revenue growth ADMA Biologics free cash flow Supernus Pharmaceuticals free cash flow

ADMA Biologics & Supernus Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.